BriaCell Therapeutics Corporation
Nasdaq BCTX · West Vancouver, British Columbia, Canada
Works in Dermatology · Oncology
BriaCell Therapeutics Corporation is a clinical trial sponsor based in West Vancouver, British Columbia, Canada, listed as Nasdaq BCTX. It has 1 active clinical trial with 404 planned participants, in Dermatology and Oncology. Since 2021 it has completed 2 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq BCTX
Fundraising
Pipeline · 1 active trial
| Stage | Trial | Status |
|---|---|---|
Questions about BriaCell Therapeutics Corporation
BriaCell Therapeutics Corporation is lead sponsor of 1 active clinical trial on ClinicalTrials.gov, with 404 planned participants, in Dermatology, Oncology. Since 2021 it has completed 2 trials and stopped 0 early.
BriaCell Therapeutics Corporation is based in West Vancouver, British Columbia, Canada and is listed as Nasdaq BCTX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with BriaCell Therapeutics Corporation; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-02.
Approve Suite is not affiliated with BriaCell Therapeutics Corporation.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.